ArticleRadiology case reports2025
Follicular carcinoma of the thyroid with a single metastatic lesion in the skull: A case report.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular thyroid carcinoma (FTC) represents a significant subset of thyroid malignancies following papillary thyroid cancer (PTC), constituting approximately 10% of all thyroid cancers. Surgical excision of metastatic lesions remains the cornerstone of treatment due to its potential for cure, symptom relief, and favorable response to radioactive iodine therapy. We present an exceedingly rare case involving a 79-year-old woman with a history of thyroidectomy 18 years prior, who presented to our hospital, Kashan Shahid Beheshti Hospital, with metastatic follicular thyroid carcinoma to the skull. FTC is characterized by early hematogenous spread, with the bone representing a typical site of metastasis. In patients diagnosed with FTC, large tumor size and presence of bone metastases are indicative of poor prognostic factors. However, the presence of a solitary bone metastasis should not preclude aggressive therapeutic interventions. Appropriate management strategies can lead to improved outcomes and enhanced quality of life for affected individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.